Search Saint Luke's

Liver Cancer

An Interventional Open-label Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

The Cardiovascular Outcomes Research Postdoctoral Fellowship at Saint Luke’s Mid America Heart Institute is a National Institutes of Health T32 training program.

Saint Luke’s dedication to research means more patients have alternatives to care—like Hilda Lankard and Agnes Lickteig.

In a new analysis, researchers looked at how older patients in the ISCHEMIA trial responded to invasive strategy compared with more conservative management.

A new study co-led by a Saint Luke's researcher found that EMS practices for out-of-hospital cardiac arrest (OHCA) are different in predominantly Black/Hispanic areas compared to mostly white areas.

A new study co-led by a Saint Luke's researcher found that it may be possible to safely cut back on the level of monitoring of patients with stroke after thrombolysis administration.

TCTMD talked to Dr. Paul Chan and Dr. Anezi Uzendu about the new study's findings.

Following years of steady improvements in outcomes, more recent observational data suggest that mortality among TAVI patients may be increasing.

TCTMD talked to Dr. Vittal Hejjaji about a large registry study that looked at when patients quit smoking following an atherosclerotic cardiovascular disease event.

TCTMD talked to Dr. Adam Salisbury about what researchers found in the newly published OPTIMUM study.